The Growing Global Threat Of Antibiotic Resistance Ielts Reading Answers Verified _top_

The problem of antibiotic resistance is not new, but it has escalated in recent years. In the 1940s and 1950s, antibiotics such as penicillin and streptomycin revolutionized the treatment of bacterial infections. However, the widespread use of antibiotics in human medicine and agriculture has accelerated the emergence of antibiotic-resistant bacteria.

Keeping new breakthrough antibiotics as a "last resort" has financial disadvantages for pharmaceutical corporations.

: Companies prefer investing in chronic condition treatments over antibiotics due to higher profit margins, or a more lucrative market.

Explanation: While a "One Health" approach is part of global discourse, the passage does not state that it has been implemented to successfully eliminate superbugs in Europe. The problem of antibiotic resistance is not new,

Answer: FALSE

The ramifications of a post-antibiotic era extend far beyond prolonged hospital stays and escalating healthcare expenditures. Advanced medical procedures that society takes for granted—such as chemotherapy, organ transplantations, joint replacements, and neonatal care—rely entirely on prophylactic antibiotics to protect immunocompromised patients. Without effective antimicrobial shields, these life-saving interventions could become prohibitively hazardous.

This public link is valid for 7 days and shares a thread, including any personal information you added. This link or copies made by others cannot be deleted. If you share with third parties, their policies apply. Can’t copy the link right now. Try again later. Keeping new breakthrough antibiotics as a "last resort"

For pharmaceutical companies, the return on investment (ROI) for antibiotics is notoriously low. Unlike chronic medications for hypertension or diabetes, which patients take daily for decades, antibiotics are short-course curative drugs used for a week or two. Furthermore, when a breakthrough antibiotic is discovered, medical guidelines dictate that it should be kept on the shelf as a "last resort" to prevent bacteria from developing resistance to it. Consequently, sales volumes remain low. This economic reality has driven major pharmaceutical firms out of antibiotic research, leaving the field dangerously underfunded. Combating the Threat: A Unified Approach

If you see a question about the primary cause of resistance, the verified answer key almost always points to overuse and misuse in human medicine and agriculture , not a lack of hygiene or poor hospital cleaning.

The race is far from lost—but time is not on humanity’s side. Every unnecessary antibiotic prescription, every incomplete course of treatment, every kilogram of antibiotics fed to healthy livestock, adds fuel to an already blazing fire. As one passage aptly concludes: “If innovation in research were encouraged, and new tools developed, the WHO argued, the threat might yet be contained. But herein lies the biggest challenge of all.” Answer: FALSE The ramifications of a post-antibiotic era

(Explanation: The passage explicitly mentions that educational campaigns aim to inform the public about the dangers of misuse and overuse of antibiotics).

| Question | Answer | Type | |----------|--------|------| | Questions 1-11 | Various (refer to passage-specific answer key) | Multiple/Short Answer | | 12 | E (Innovation in research) | Matching | | 13 | A (Collaboration with policymakers for funding) | Matching | | 14 | D (Development of new tools by WHO) | Matching |

To revitalize drug discovery, international bodies and governments are exploring new economic models. "Push" incentives, such as research grants, reduce early-stage financial risks, while "pull" incentives, like market entry rewards or subscription-style payment models, guarantee a payout for successful drug development regardless of sales volume.

The issue of antimicrobial resistance represents one of the most significant public health crises of the twenty-first century. As bacteria evolve to defeat the defensive mechanisms of modern medicine, global healthcare infrastructure faces an unprecedented destabilization. For candidates preparing for the International English Language Testing System (IELTS), topics surrounding medical science, global health threats, and evolutionary biology are frequent features in the Academic Reading component. Understanding the historical context, biological mechanisms, and international strategies associated with antibiotic resistance not only provides valuable contextual knowledge but also sharpens the analytical skills required to navigate dense, information-rich texts.

A common "stumbling block" mentioned in IELTS texts is the lack of new drug development. Pharmaceutical companies often prioritize more "lucrative" drugs for chronic conditions (like asthma or heart disease) over antibiotics, which are relatively inexpensive and used for short periods.